In patients treated with ICIs, further amplification of their MDM2 gene results in loss of function of the p53 tumor suppressor activity, leading to apoptosis and cell cycle arrest, which in turn accelerates tumor progression and the occurrence of HPD. This evidence concerns the gene TP53 and neoplasm.